NASDAQ:TGTX

Tg Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy TGTX

*Your capital is at risk

$40.11

+3.47 (+9.47%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

TGTX Prediction Chart

TGTX Predictions History

Latest community submissions for TGTX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy
Blah	Mar 10, 2017	$12.20 +7.02%	$11.40	X	93.00%
JS Pro	Mar 10, 2017	$12.50 +9.65%	$11.40	X	90.40%
Scott.Boice.3225	Feb 24, 2017	$6.00 +1.69%	$5.90	X	98.30%
JS Pro	Sep 1, 2016	$6.11 -6.14%	$6.51	X	93.90%

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for TGTX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT TG THERAPEUTICS

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and relapsing forms of multiple sclerosis; and Umbra...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by